| Literature DB >> 28621325 |
Stian A Engen1, Gro H Rørvik1, Olav Schreurs1, Inger Js Blix1,2, Karl Schenck1.
Abstract
Streptococcus mitis (S. mitis) is a pioneer commensal bacterial species colonizing many of the surfaces of the oral cavity in healthy individuals. Yet, not much information is available regarding its interaction with the host. We used examination of its transcriptional regulation in oral keratinocytes to elucidate some of its potential roles in the oral cavity. Transcription factor analysis of oral keratinocytes predicted S. mitis-mediated activation of aryl hydrocarbon receptor (AhR). Activation and functionality of AhR was confirmed through nuclear translocation determined by immunofluorescence microscopy and real-time polymerase chain reaction with reverse transcription analysis of CYP1A1, the hallmark gene for AhR activation. Addition of Streptococcus mutans or Streptococcus gordonii did not induce CYP1A1 transcription in the keratinocyte cultures. Introduction of an AhR-specific inhibitor revealed that S. mitis-mediated transcription of CXCL2 and CXCL8 was regulated by AhR. Elevated levels of prostaglandin E2 (enzyme-linked immunosorbent assay) in supernatants from S. mitis-treated oral epithelial cells were also attenuated by inhibition of AhR activity. The observed AhR-regulated activities point to a contribution of S. mitis in the regulation of inflammatory responses and thereby to wound healing in the oral cavity. The concept that the oral commensal microbiota can induce AhR activation is important, also in view of the role that AhR has in modulation of T-cell differentiation and as an anti-inflammatory factor in macrophages.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28621325 PMCID: PMC5709542 DOI: 10.1038/ijos.2017.17
Source DB: PubMed Journal: Int J Oral Sci ISSN: 1674-2818 Impact factor: 6.344
List of transcriptional regulators with predicted altered activity in response to S. mitis lysate.
| Upstream regulator | Molecule type | Predicted activation state | Activation |
|---|---|---|---|
| Heat shock factor protein 1 | Transcription regulator | Activated | 3 098 |
| Paired box protein Pax-7 | Transcription regulator | Activated | 3 030 |
| Hairy/enhancer-of-split related with YRPW motif protein 1 | Transcription regulator | Activated | 2 586 |
| Myocyte-specific enhancer factor 2C | Transcription regulator | Activated | 2 578 |
| Heart- and neural crest derivatives-expressed protein 1 | Transcription regulator | Activated | 2 449 |
| CCAAT/enhancer-binding protein alpha | Transcription regulator | Activated | 2 430 |
| Estrogen receptor beta | Ligand-dependent nuclear receptor | Activated | 2 392 |
| Aryl hydrocarbon receptor | Ligand-dependent nuclear receptor | Activated | 2 368 |
| Transcription factor Sp3 | Transcription regulator | Activated | 2 360 |
| Transcription factor Dp-1 | Transcription regulator | Activated | 2 330 |
| X-box-binding protein 1 | Transcription regulator | Activated | 2 253 |
| CCAAT/enhancer-binding protein beta | Transcription regulator | Activated | 2 224 |
| Krueppel-like factor 1 | Transcription regulator | Activated | 2 213 |
| Early growth response protein 1 | Transcription regulator | Activated | 2 197 |
| Peroxisome proliferator-activated receptor gamma coactivator 1-alpha | Transcription regulator | Activated | 2 173 |
| Methyl-CpG-binding domain protein 2 | Transcription regulator | Activated | 2 128 |
| Sterol regulatory element-binding protein 1 | Transcription regulator | Activated | 2 095 |
| Histone acetyltransferase KAT5 | Transcription regulator | Activated | 2 025 |
| WW domain-containing transcription regulator protein 1 | Transcription regulator | Activated | 2 000 |
| Cyclic AMP-responsive element-binding protein 3-like protein 4 | Transcription regulator | Activated | 2 000 |
| Hepatic leukemia factor | Transcription regulator | Inhibited | −2 000 |
| Transcriptional repressor protein YY1 | Transcription regulator | Inhibited | −2 021 |
| COP9 signalosome complex subunit 5 | Transcription regulator | Inhibited | −2 155 |
| Transcription regulator protein BACH1 | Transcription regulator | Inhibited | −2 172 |
| Nuclear factor 1 C-type | Transcription regulator | Inhibited | −2 236 |
| Death domain-associated protein 6 | Transcription regulator | Inhibited | −2 392 |
| Kelch-like ECH-associated protein 1 | Transcription regulator | Inhibited | −2 408 |
| Nuclear receptor ROR-alpha | Ligand-dependent nuclear receptor | Inhibited | −2 579 |
| Proto-oncogene c-Rel | Transcription regulator | Inhibited | −2 868 |
List of top five biological processes affected by the downstream target genes of the 20 activated (342 target genes) and nine inhibited (95 target genes) transcription factors
| Pathway ID | Pathway description | Count | |
|---|---|---|---|
| Activated | |||
| GO:0010033 | Response to organic substance | 133 | |
| GO:0031325 | Positive regulation of cellular metabolic process | 141 | |
| GO:0070887 | Cellular response to chemical stimulus | 124 | |
| GO:0009893 | Positive regulation of metabolic process | 148 | |
| GO:0010604 | Positive regulation of macromolecule metabolic process | 128 | |
| Inhibited | |||
| GO:1901700 | Response to oxygen-containing compound | 35 | |
| GO:0042981 | Regulation of apoptotic process | 34 | |
| GO:0010941 | Regulation of cell death | 34 | |
| GO:0043067 | Regulation of programmed cell death | 33 | |
| GO:0048583 | Regulation of response to stimulus | 48 |
Figure 1. (a) Nuclear translocation of AhR was examined by immunofluorescence microscopy of human primary oral keratinocytes, cultivated and exposed to live S. mitis for 20 min (right) or left untreated (left). Cells were stained for AhR (upper row; green) and DAPI (middle row; red). Merged pictures in the lower row. (b) Fold changes in the transcription of CYP1A1, the hallmark gene of AhR activation, determined by real-time RT-PCR in human primary oral keratinocytes exposed to live S. mitis (left), S. gordonii (middle) and S. mutans (right) for 90 min, with or without the AhR-specific inhibitor CH-223191 (n=3 or 4). Brackets marked with asterisks indicate statistically significance (ANOVA for repeated measures followed by Holm–Sidak adjustment for multiple comparisons; P<0.05). ANOVA, analysis of variance.
Figure 2Fold changes in the transcription of chemoattractants CXCL1 (a), CXCL2 (b) and CXCL8 (c) were determined by real-time RT-PCR in human primary oral keratinocytes exposed to live S. mitis for 90 min, with or without the AhR-specific inhibitor CH-223191 (n=4). Brackets marked with asterisks indicate statistically significance (ANOVA for repeated measures followed by Holm–Sidak adjustment for multiple comparisons; P<0.05). ANOVA, analysis of variance.
Figure 3Oral epithelial cells exposed to Human primary oral keratinocytes were exposed for 6 h to live S. mitis and/or the AhR-specific inhibitor CH-223191 or left untreated. Supernatants were collected and their PGE2 content was measured by ELISA (n=4). Brackets marked with asterisks indicate statistically significance (ANOVA for repeated measures followed by Holm–Sidak adjustment for multiple comparisons; P<0.05). ANOVA, analysis of variance.